Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users

M. BOURLIÈRE ; J. M. BARBERIN ; M. ROTILY ; V. GUAGLIARDO ; I. PORTAL ; L. LECOMTE ; S. BENALI ; C. BOUSTIÈRE ; H. PERRIER ; M. JULLIEN ; G. LAMBOT ; R. LOYER ; O. LEBARS ; R. DANIEL ; H. KHIRI ; P. HALFON | 2002
Dans Journal of Viral Hepatitis (Vol.9, n°1, January 2002) Article : Périodique

Hepatitis C virus (HCV) genotypes are distributed differently depending on geography and route of infection. We characterized the distribution of genotypes in a large cohort of patients with chronic hepatitis C in the South-east of France and ev[...]

Plus d'info

Ajouter à la sélection

Evidence Map of Systematic Reviews (SRs) to inform the prevention, treatment and/or harm reduction for illicit drug use : Commissioned by the Institute for Neuroscience, Mental Health & Addiction, Canadian Institutes for Health Research (CIHR). Ottawa Methods Centre, Knowledge Synthesis Group Technical Report

Ottawa Methods Centre, Knowledge Synthesis Group ; C. GARRITTY ; M. ANSARI ; F. YAZDI ; K. SINGH ; J. GALIPEAU ; M. PRATT ; M. YOUNG ; R. SKIDMORE ; R. DANIEL ; D. MOHER ; J. GRIMSHAW | 2011
Rapport

GUIDING QUESTION & PRIORITIZATION: • The guiding objective for this mapping exercise was to determine what systematic reviews (SRs) exist to inform the prevention, treatment and/or harm reduction for illicit drug use. • The intent was to descr[...]

Plus d'info

Ajouter à la sélection